Home : Unsafe Drugs : Provigil : Newsfeeds

Provigil - Newsfeeds

Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited: FRAZER, Pa. and MELBOURNE, Australia , March 28, 2011 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH - News ) and ChemGenex Pharmaceuticals Limited (ASX: CXS.ax - News ) today jointly announced that Cephalon's wholly-owned subsidiary, Cephalon CXS Holdings ...
Wall Street rides winners as quarter winds down: NEW YORK (Reuters) - U.S. stocks rose on Wednesday with activity dominated by money managers buying recent winners, including energy and small-caps, as the quarter nears its end. But trading volume remained weak and the S&P 500 failed to hold above 1,330 ...
Watson's Prochieve Achieves Target: Watson Pharmaceuticals Inc. (NYSE: WPI - News ) and partner Columbia Laboratories Inc. (NasdaqGM: CBRX - News ) recently announced positive data on Prochieve which was being studied for the reduction of the risk of preterm birth in women with a short ...
Valeant to be disciplined in Cephalon bid: CEO: TORONTO (Reuters) - Valeant Pharmaceuticals International Inc (Toronto: VRX.TO - News ; NYSE: VRX - News ) is not interested in a bidding war for U.S. drugmaker Cephalon Inc (NasdaqGS: CEPH - News ), and Chief Executive Michael Pearson said on Wednesday he ...
EU investigates Cephalon/Teva modafinil agreement: BRUSSELS, April 28 (Reuters) - EU regulators have opened an antitrust probe into an agreement between U.S.-based Cephalon Inc.( CEPH.O ) and Israel's Teva Pharmaceutical Industries ( TEVA.TA ) on generic modafinil in the European market. The European ...
Fewer people applied for unemployment benefits last week, after a big jump the previous week: The Labor Department said Thursday that the number of people applying for unemployment benefits dropped 13,000 to a seasonally adjusted 403,000 in the week ending April 16. The decline comes after applications rose 31,000 a week earlier. Applications near ...
Cephalon file depinitibo Pahintulot pagbawi Pahayag, inirekomenda shareholders upang tanggihan Valeant's panukala: (3) Ang iyong Board at management team ay isang napatunayan na kasaysayan ng pagbuo ng compounds huli-stage tulad ng PROVIGIL, NUVIGIL , FENTORA at TREANDA, bukod sa iba. Ang iyong Board naniniwala na ang mga programang ito ay kumakatawan ng makabuluhang ...
Mexico agency confirms $1B fine for Slim's company: Mexico's antitrust agency confirmed Sunday that it levied a $1 billion (12 billion peso) fine against the Mexican cellphone subsidiary of tycoon Carlos Slim and ordered it to stop unfair practices. The Federal Competition Commission said it found that Slim ...
BUYINS.NET: CAT, PFE, HD, DIS, CHK, CEPH Expected To Be Up Before Next Earnings Releases: Its products for central nervous system disorders include PROVIGIL for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder; NUVIGIL, a single-isomer formulation of ...
European regulators investigate Cephalon: (AP) -- European Union antitrust regulators said Thursday they are investigating whether drug makers Cephalon and Teva were working to keep a generic version of sleep-disorder drug Provigil out of the European market. U.S.-based Cephalon Inc. and Israel ...

EU probes Teva, Cephalon deal on sleeping drug: Liechtenstein, and Norway before Oct. 2012, the EU's competition watchdog said. The European Commission is now probing whether that agreement broke EU competition rules and had the "object or effect" of keeping generic Provigil out of the European market.
EU probes whether deal to keep generic Modafinil off European market broke competition rules: BRUSSELS — European Union regulators say they are investigating whether drug makers Cephalon and Teva are working to keep a generic version of sleep-disorder drug Modafinil out of the European market. The European Commission said Thursday that U.S.-based ...
EU opens anti-trust probe into stay-awake drug deal: The controversial anti-tiredness drug, marketed under the brand-name Provigil, can keep people awake for days and is normally used to treat the rare sleeping disorder narcolepsy. But it became popular among night-workers such as truckers and was even ...
EU Opens Antitrust Probe Of Cephalon, Teva Modafinil Deal: sold under the brand name Provigil. According to the deal, Teva undertook not to sell its generic version of Modafinil in Europe before October 2012, the commission explained. The EU has been targeting the pharmaceutical sector to make sure that deals to ...
EU investigates Cephalon/Teva modafinil agreement: Modafinil, marketed by Cephalon as Provigil, is used to treat certain sleeping disorders. The Commission said its investigation did not mean it had conclusive proof of any infringement, but that it would give the case priority.
EU launches antitrust probe into Cephalon, Teva: The U.S.-based Cephalon and Israel-based Teva, the two leading generic drugs makers in the world, in December 2005 settled patent infringement disputes in Britain and the United States concerning Modafinil, a sleep-disorder drug with brand name Provigil.
Cephalon, Teva Deal on Generics Targeted in EU Antitrust Probe: An agreement by Cephalon Inc. (CEPH) and Teva Pharmaceutical Industries Ltd. (TEVA) that may have delayed generic versions of Cephalon’s biggest product, Provigil, will be examined in a European Union investigation. The European Commission in Brussels ...
EU probes whether deal to keep generic Provigil off European market broke competition rules: BRUSSELS - European Union antitrust regulators said Thursday they are investigating whether drug makers Cephalon and Teva were working to keep a generic version of sleep-disorder drug Provigil out of the European market. U.S.-based Cephalon Inc. and Israel ...
EU examining Cephalon-Teva's generic Provigil deal: European Union regulators said Thursday they are looking into whether Cephalon and generic drug giant Teva Pharmaceuticals violated antitrust rules by agreeing to a deal under which a generic for Provigil, Cephalon’s narcolepsy and sleep disorder drug ...
Cephalon Rejects VRX' $73/Share Bid: With Provigil sales remaining strong, we remain concerned about the slower-than-expected conversion of patients to Nuvigil. Both 2012 and 2013 should be challenging years for the company due to the genericization of Provigil. We are nevertheless pleased ...

Want to contact a Provigil attorney in District of Columbia?...Get a free case evaluation from one of our Provigil attorneys in District of Columbia now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: 1 2 3 4 5 6 ... Next

Need A Provigil Attorney?

First Name Last Name Email Address State

Legal Issue

Unsafe Drugs: Provigil Click to select a Legal Issue

Was Your Health Negatively Affected?

Please Describe the Injury

close this window

Provigil Information

Click to View Our Legal Resources

Want to contact a Provigil attorney in District of Columbia?...Get a free case evaluation from one of our Provigil attorneys in District of Columbia now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120517-074135

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

Unsafe Drugs: Provigil Click to select a Legal Issue

Close (x)

Find Legal Help for Your Provigil Case - Submit Your Information Below

Do you need legal assistance with your Provigil case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * Unsafe Drugs: Provigil Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.